SCHEMBL25085773

SCHEMBL25085773

COC(=O)c1cnccc1C#N

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.54
KDM4E B2RXH2 6/20 0.54
GAA P10253 3/20 0.54
GLA P06280 2/20 0.54
LMNA P02545 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
HPGD P15428 4/20 0.42
HSD17B10 Q99714 3/20 0.42
CASP1 P29466 1/20 0.42
HTT P42858 1/20 0.42
CASP7 P55210 1/20 0.42
NCOA1 Q15788 1/20 0.42
RCE1 Q9Y256 1/20 0.42
NCOA3 Q9Y6Q9 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29467363 0.87 ALDH1A1 (0.58) ALDH1A1KDM4EGAAGLALMNA
SCHEMBL2847922 0.87 ALDH1A1 (0.58) ALDH1A1KDM4EGAAGLALMNA
SCHEMBL9173088 0.83 KDM4E (0.54) ALDH1A1KDM4EGAAGLALMNA
SCHEMBL17260712 0.81 MAPT (0.44) ALDH1A1KDM4EGAACYP1A2CYP2C9
SCHEMBL4619119 0.79 KDM4C (0.48) ALDH1A1KDM4EL3MBTL1HTTKMT2A
SCHEMBL29955774 0.79 KDM4C (0.48) ALDH1A1KDM4EL3MBTL1HTTKMT2A
SCHEMBL68952 0.78 KDM4E (0.70) ALDH1A1KDM4EGAAGLALMNA
SCHEMBL29416299 0.78 KDM4E (0.70) ALDH1A1KDM4EGAAGLALMNA
SCHEMBL30874483 0.77 SIRT3 (0.55) ALDH1A1KDM4EL3MBTL1CASP1HTT
SCHEMBL20399076 0.76 KDM4E (0.50) ALDH1A1KDM4EGAAGLALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118302417-A NLRP3 inhibitors PTC医疗公司 2024-07-05 CN disclosed
EP-4392414-A1 INHIBITORS OF NLRP3 PTC Therapeutics, Inc. (US) 2024-07-03 EP disclosed
WO-2023028534-A1 INHIBITORS OF NLRP3 PTC THERAPEUTICS, INC. (US) 2023-03-02 WO disclosed
WO-2023028534-A1 INHIBITORS OF NLRP3 PTC THERAPEUTICS, INC. (US) 2023-03-02 WO disclosed